Work

Phase 1 Study of Tru-016, An Anti-CD37 SMIP™ Protein in Naive and Relapsed and/or Refractory CLL Patients

Year: 2011

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v118.21.1792.1792

Authors: Farrukh T Awan, John M. Pagel, Leslie A Andritsos, Ajay K. Gopal, Richard R. Furman, Stephen Spurgeon, Delva Deauna-Limayo, Scott Stromatt, John C. Byrd

Institutions: Fred Hutch Cancer Center, The Ohio State University, Cornell University, Weill Cornell Medicine, OHSU Knight Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2556995775

FWCI: 0.765

Cites:

Cited by: 5

Related to: 10